Search 

Almac Discovery is a research driven drug discovery company operating within the Almac Group of companies dedicated to the development of novel and innovative approaches to the treatment of diseases of unmet need (including oncology and CNS). Our business model is primarily to discover and develop novel First-in-Class drug candidates through to pre-clinical development, and then to seek pharmaceutical or biotech partners for clinical development and commercialisation. Key research themes are two-fold: a) Controlling protein homeostasis through targeting Deubiquitinase (DUB) enzymes, and, b) Generating novel protein drug conjugates (PDCs) utilising single chain antigen recognition domains linked to Almac’s proprietary linker:payload technology.

The Almac Group is an established contract development and manufacturing organisation that provides the most unique range of integrated drug development services available to the pharmaceutical & biotech industry.